Similar articles for PMID: 19331179

Year	Number of Results
1963	1
1996	1
2000	2
2001	2
2002	3
2003	3
2004	7
2005	13
2006	22
2007	13
2008	25
2009	31
2010	3
2011	5
2012	5
2013	7
2014	4
2015	7
2016	7
2017	5
2018	6
2019	6
2020	5
2021	4
2022	3
2023	1
2024	0

1

Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.

Iurisci I, Cumashi A, Sherman AA, Tsvetkov YE, Tinari N, Piccolo E, D'Egidio M, Adamo V, Natoli C, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale Per la Bio-Oncologia. Iurisci I, et al. Anticancer Res. 2009 Jan;29(1):403-10. Anticancer Res. 2009. PMID: 19331179 Free article.

2

Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis.

Rabinovich GA, Cumashi A, Bianco GA, Ciavardelli D, Iurisci I, D'Egidio M, Piccolo E, Tinari N, Nifantiev N, Iacobelli S. Rabinovich GA, et al. Glycobiology. 2006 Mar;16(3):210-20. doi: 10.1093/glycob/cwj056. Epub 2005 Nov 10. Glycobiology. 2006. PMID: 16282605

3

Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.

Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP. Glinsky VV, et al. Cancer Res. 2000 May 15;60(10):2584-8. Cancer Res. 2000. PMID: 10825125

4

Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.

Ahmad N, Gabius HJ, Sabesan S, Oscarson S, Brewer CF. Ahmad N, et al. Glycobiology. 2004 Sep;14(9):817-25. doi: 10.1093/glycob/cwh095. Epub 2004 May 17. Glycobiology. 2004. PMID: 15148296

5

Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.

Rapoport EM, André S, Kurmyshkina OV, Pochechueva TV, Severov VV, Pazynina GV, Gabius HJ, Bovin NV. Rapoport EM, et al. Glycobiology. 2008 Apr;18(4):315-24. doi: 10.1093/glycob/cwn009. Epub 2008 Feb 6. Glycobiology. 2008. PMID: 18256179

6

Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.

Ulmer TA, Keeler V, Loh L, Chibbar R, Torlakovic E, André S, Gabius HJ, Laferté S. Ulmer TA, et al. J Cell Biochem. 2006 Aug 1;98(5):1351-66. doi: 10.1002/jcb.20784. J Cell Biochem. 2006. PMID: 16518858

7

Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.

Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL. Zou J, et al. Carcinogenesis. 2005 Feb;26(2):309-18. doi: 10.1093/carcin/bgh329. Epub 2004 Nov 4. Carcinogenesis. 2005. PMID: 15528216

8

Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.

Inohara H, Akahani S, Koths K, Raz A. Inohara H, et al. Cancer Res. 1996 Oct 1;56(19):4530-4. Cancer Res. 1996. PMID: 8813152

9

On the role of galectin-3 in cancer apoptosis.

Nakahara S, Oka N, Raz A. Nakahara S, et al. Apoptosis. 2005 Mar;10(2):267-75. doi: 10.1007/s10495-005-0801-y. Apoptosis. 2005. PMID: 15843888 Review.

10

Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.

Suzuki O, Nozawa Y, Abe M. Suzuki O, et al. Oncol Rep. 2005 Jan;13(1):109-14. Oncol Rep. 2005. PMID: 15583810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

172 results

Results by year